Activated platelet phospholipid membrane surface (PPS)

The activated platelet phospholipid membrane surface is a critical catalytic platform for the blood coagulation cascade. Upon activation by agonists such as thrombin or collagen, platelets undergo a loss of membrane phospholipid asymmetry, a process mediated by scramblase enzymes that externalize phosphatidylserine (PS) to the outer leaflet (Zwaal & Schroit, 1997). This negatively charged surface facilitates the calcium-dependent binding of vitamin K-dependent clotting factors, allowing for the assembly of the tenase and prothrombinase complexes (Heemskerk et al., 2002). The concentration of these factors on the membrane surface increases the rate of thrombin generation by several orders of magnitude compared to reactions in the fluid phase (Mann et al., 1990). Pathologically, the excessive availability of this procoagulant surface is a major contributor to arterial and venous thrombosis, leading to myocardial infarction and stroke (StatPearls, 2023). Most clinical anticoagulants, such as rivaroxaban and heparin, function by inhibiting the enzymatic complexes that form on this surface, while experimental agents like Annexin V derivatives are designed to bind directly to the exposed phospholipids to block the initiation of coagulation (Post et al., 2004).

Other names

Procoagulant phospholipid surfaceAnionic phospholipid membranePhosphatidylserine-exposed membranePlatelet procoagulant surface

Provides a catalytic scaffold for the assembly of the tenase (IXa/VIIIa) and prothrombinase (Xa/Va) complexes, facilitating the rapid conversion of prothrombin to thrombin (Mann et al., 1990; Zwaal & Schroit, 1997).